Novasign Blog

Updated: Apr 10, 2020 Have you ever used design of experiments (DoE) tools to...

In order to move from industry 3.0 to 4.0 relevant process outputs (titer, product quality,...

Process development in a QbD approach is accompanied by high experimental effort due to a...

At Novasign we’ve always been driven by the passion to innovate and optimize. Our...

Emerging manufacturing technologies to treat diseases derived from monogenic disorders are of...

Updated: Apr 10, 2020 Last week we have been to Bioprocessing Europe in Lisbon. The...

Updated: Apr 10, 2020 From the 17th to the 20th of September, the 10th ÖGMBT Annual...

Updated: Apr 10, 2020 In 2018 the generated revenue by biopharmaceuticals is...